O'Toole Paul W, Flemer Burkhardt
Department of Microbiology, APC Microbiome Institute, University College Cork, Cork, Ireland.
Semin Liver Dis. 2016 Sep;36(4):306-311. doi: 10.1055/s-0036-1594008. Epub 2016 Dec 20.
The term refers to the collection of microbes or microbial genes in a specified location or clinical sample. Identifying micro-organisms has historically relied upon bacteriological culture, which is time consuming and difficult to effectively implement. The recent adaptation of culture-independent techniques for profiling microbial communities, allied with next-generation massively parallel DNA sequencing, allows clinician scientists to determine the entire microbial content of a specimen to a forensic level of detail within 48 hours. The technology is still young, and the main thrust of current efforts is to identify how changes in the microbiome covary with a variety of syndromes and diseases, and to determine if these changes are causative or consequential. Regardless of the outcome of these investigations, it is already apparent that the gut microbiome is a useful biomarker for intestinal and extraintestinal disease. In this review, the authors summarize the main concepts in microbiome analysis, and prospects for the microbiome's clinical deployment.
该术语指特定位置或临床样本中的微生物或微生物基因集合。历史上,鉴定微生物一直依赖细菌培养,这既耗时又难以有效实施。最近,与新一代大规模平行DNA测序相结合的非培养技术被用于分析微生物群落,使临床科学家能够在48小时内将标本的整个微生物含量测定到法医级别的细节。这项技术仍处于起步阶段,目前工作的主要重点是确定微生物组的变化如何与各种综合征和疾病共同变化,并确定这些变化是因果关系还是继发关系。无论这些研究的结果如何,肠道微生物组显然已是肠道和肠外疾病的有用生物标志物。在本综述中,作者总结了微生物组分析的主要概念以及微生物组临床应用的前景。